Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab
Clinical trial NCT01442649 · COMPLETED
Trial details
- NCT number
- NCT01442649
- Sponsor
- UNICANCER
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2015-10-01
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.